Gene · 5916
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis. | Front Genet | 2022 | 36437956 | PubTator, text mining | PubMed |
| Single-cell multiomics reveals the complexity of TGFβ signalling to chromatin in iPSC-derived kidney organoids. | Commun Biol | 2022 | 36435939 | PubTator, text mining | PubMed |
| The Molecular Signature of Human Testicular Peritubular Cells Revealed by Single-Cell Analysis. | Cells | 2022 | 36429113 | PubTator, text mining | PubMed |
| Screening of Adapalene Microsponges Fabrication Parameters with Insight on the In vitro Biological Effectiveness. | Drug Des Devel Ther | 2022 | 36388080 | PubTator, text mining | PubMed |
| Retinoic Acid Receptor Gamma (RARγ) Promotes Cartilage Destruction through Positive Feedback Activation of NF-κB Pathway in Human Osteoarthritis. | Mediators Inflamm | 2022 | 36387933 | PubTator, text mining | PubMed |
| Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies. | Front Oncol | 2022 | 36387198 | PubTator, text mining | PubMed |
| Enhancement of Efficacy of Retinoids through Enhancing Retinoid-Induced RAR Activity and Inhibiting Hydroxylation of Retinoic Acid, and Its Clinical Efficacy on Photo-Aging. | Pharmaceutics | 2022 | 36365229 | PubTator, text mining | PubMed |
| Translational Regulation by eIFs and RNA Modifications in Cancer. | Genes (Basel) | 2022 | 36360287 | PubTator, text mining | PubMed |
| Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. | Cancers (Basel) | 2022 | 36358854 | PubTator, text mining | PubMed |
| Three-dimensional microenvironment regulates gene expression, function, and tight junction dynamics of iPSC-derived blood-brain barrier microvessels. | Fluids Barriers CNS | 2022 | 36333694 | PubTator, text mining | PubMed |
| All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity. | PLoS One | 2022 | 36331922 | PubTator, text mining | PubMed |
| Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers. | J Med Chem | 2022 | 36318154 | PubTator, text mining | PubMed |
| Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future. | Front Cardiovasc Med | 2022 | 36312261 | PubTator, text mining | PubMed |
| The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review. | Int J Mol Sci | 2022 | 36293471 | PubTator, text mining | PubMed |
| Direct Reprogramming of Mouse Subchondral Bone Osteoblasts into Chondrocyte-like Cells. | Biomedicines | 2022 | 36289842 | PubTator, text mining | PubMed |
| Development and function of regulatory innate lymphoid cells. | Front Immunol | 2022 | 36275689 | PubTator, text mining | PubMed |
| Recognition of fold- and function-specific sites in the ligand-binding domain of the thyroid hormone receptor-like family. | Front Endocrinol (Lausanne) | 2022 | 36246927 | PubTator, text mining | PubMed |
| Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis. | Cells | 2022 | 36230951 | PubTator, text mining | PubMed |
| Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies. | Cancers (Basel) | 2022 | 36230587 | PubTator, text mining | PubMed |
| A Novel tiRNA-Gly-GCC-1 Promotes Progression of Urothelial Bladder Carcinoma and Directly Targets TLR4. | Cancers (Basel) | 2022 | 36230476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5916/papers?page=16